Last reviewed · How we verify
Single anti-platelet therapy — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Single anti-platelet therapy (Single anti-platelet therapy) — Lepu Medical Technology (Beijing) Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Single anti-platelet therapy TARGET | Single anti-platelet therapy | Lepu Medical Technology (Beijing) Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Single anti-platelet therapy CI watch — RSS
- Single anti-platelet therapy CI watch — Atom
- Single anti-platelet therapy CI watch — JSON
- Single anti-platelet therapy alone — RSS
Cite this brief
Drug Landscape (2026). Single anti-platelet therapy — Competitive Intelligence Brief. https://druglandscape.com/ci/single-anti-platelet-therapy. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab